Literature DB >> 22152304

Impairment of central leptin-mediated PI3K signaling manifested as hepatic steatosis independent of hyperphagia and obesity.

James P Warne1, Farzad Alemi, Alison S Reed, Jillian M Varonin, Helen Chan, Merisa L Piper, Mark E Mullin, Martin G Myers, Carlos U Corvera, Allison W Xu.   

Abstract

Hepatic steatosis is generally thought to develop via peripheral mechanisms associated with obesity. We show that chronic central infusion of leptin suppresses hepatic lipogenic gene expression and reduces triglyceride content via stimulation of hepatic sympathetic activity. This leptin function is independent of feeding and body weight but requires phosphatidylinositol 3-kinase (PI3K) signaling. Attenuation of leptin-induced PI3K signaling, brought about by transgenic expression of phosphatase and tensin homolog (PTEN) in leptin receptor neurons, leads to decreased hepatic sympathetic tone and increased triglyceride levels without affecting adiposity or hepatic insulin signaling. Central leptin's effects on hepatic norepinephrine levels and triglyceride content are blunted in these mutant mice. Simultaneous downregulation of PI3K and signal transducer and activator of transcription-3 (Stat3) in leptin receptor neurons does not exacerbate obesity but causes more severe hepatic steatosis. Together, our results indicate that central cellular leptin resistance in PI3K signaling manifests as hepatic steatosis without causing obesity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID: 22152304      PMCID: PMC3240844          DOI: 10.1016/j.cmet.2011.11.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  44 in total

1.  Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.

Authors:  Lazaros C Foukas; Marc Claret; Wayne Pearce; Klaus Okkenhaug; Stephen Meek; Emma Peskett; Sara Sancho; Andrew J H Smith; Dominic J Withers; Bart Vanhaesebroeck
Journal:  Nature       Date:  2006-04-12       Impact factor: 49.962

2.  Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.

Authors:  Sudha B Biddinger; Makoto Miyazaki; Jeremie Boucher; James M Ntambi; C Ronald Kahn
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

3.  Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity.

Authors:  Kenji Uno; Hideki Katagiri; Tetsuya Yamada; Yasushi Ishigaki; Takehide Ogihara; Junta Imai; Yutaka Hasegawa; Junhong Gao; Keizo Kaneko; Hiroko Iwasaki; Hisamitsu Ishihara; Hironobu Sasano; Kouichi Inukai; Hiroyuki Mizuguchi; Tomoichiro Asano; Masakazu Shiota; Masamitsu Nakazato; Yoshitomo Oka
Journal:  Science       Date:  2006-06-16       Impact factor: 47.728

Review 4.  Monogenic obesity in humans.

Authors:  I Sadaf Farooqi; Stephen O'Rahilly
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

5.  Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue.

Authors:  Nilda Gallardo; Elena Bonzón-Kulichenko; Teresa Fernández-Agulló; Eduardo Moltó; Sergio Gómez-Alonso; Pablo Blanco; Jose Maria Carrascosa; Manuel Ros; Antonio Andrés
Journal:  Endocrinology       Date:  2007-09-06       Impact factor: 4.736

6.  Disruption of peripheral leptin signaling in mice results in hyperleptinemia without associated metabolic abnormalities.

Authors:  Kaiying Guo; Julie E McMinn; Thomas Ludwig; Yi-Hao Yu; Guoqing Yang; Lulu Chen; Daniella Loh; Cai Li; Streamson Chua; Yiying Zhang
Journal:  Endocrinology       Date:  2007-05-10       Impact factor: 4.736

7.  Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.

Authors:  Mara Monetti; Malin C Levin; Matthew J Watt; Mini P Sajan; Stephen Marmor; Brian K Hubbard; Robert D Stevens; James R Bain; Christopher B Newgard; Robert V Farese; Andrea L Hevener; Robert V Farese
Journal:  Cell Metab       Date:  2007-07       Impact factor: 27.287

Review 8.  Selective versus total insulin resistance: a pathogenic paradox.

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

9.  Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.

Authors:  Sudha B Biddinger; Antonio Hernandez-Ono; Christian Rask-Madsen; Joel T Haas; José O Alemán; Ryo Suzuki; Erez F Scapa; Chhavi Agarwal; Martin C Carey; Gregory Stephanopoulos; David E Cohen; George L King; Henry N Ginsberg; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

Review 10.  Leptin receptor signaling and action in the central nervous system.

Authors:  Rebecca L Leshan; Marie Björnholm; Heike Münzberg; Martin G Myers
Journal:  Obesity (Silver Spring)       Date:  2006-08       Impact factor: 5.002

View more
  21 in total

Review 1.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 2.  Evidence for central regulation of glucose metabolism.

Authors:  Michelle Carey; Sylvia Kehlenbrink; Meredith Hawkins
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

3.  Smell and Taste Dysfunction Is Associated with Higher Serum Total Cholesterol Concentrations in Chinese Adults.

Authors:  Zhe Huang; Shue Huang; Hongliang Cong; Zheng Li; Junjuan Li; Kathleen L Keller; Gregory C Shearer; Penny M Kris-Etherton; Shouling Wu; Xiang Gao
Journal:  J Nutr       Date:  2017-06-14       Impact factor: 4.798

4.  Molecular Basis of Insulin Resistance: The Role of IRS and Foxo1 in the Control of Diabetes Mellitus and Its Complications.

Authors:  Shaodong Guo
Journal:  Drug Discov Today Dis Mech       Date:  2013-06-01

Review 5.  Central nervous system dysfunction in obesity-induced hypertension.

Authors:  Geoffrey A Head; Kyungjoon Lim; Benjamin Barzel; Sandra L Burke; Pamela J Davern
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

6.  Leptin receptor signaling in the hypothalamus regulates hepatic autonomic nerve activity via phosphatidylinositol 3-kinase and AMP-activated protein kinase.

Authors:  Mamoru Tanida; Naoki Yamamoto; Donald A Morgan; Yasutaka Kurata; Toshishige Shibamoto; Kamal Rahmouni
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

Review 7.  Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies.

Authors:  Janine J Geerling; Mariëtte R Boon; Sander Kooijman; Edwin T Parlevliet; Louis M Havekes; Johannes A Romijn; Illiana M Meurs; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2013-11-27       Impact factor: 5.922

Review 8.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

9.  Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.

Authors:  Jennifer M Rojas; John M Stafford; Sanaz Saadat; Richard L Printz; Annette G Beck-Sickinger; Kevin D Niswender
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-16       Impact factor: 4.310

10.  Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein.

Authors:  James P Warne; Jillian M Varonin; Sofie S Nielsen; Louise E Olofsson; Christopher B Kaelin; Streamson Chua; Gregory S Barsh; Suneil K Koliwad; Allison W Xu
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.